title: Regression of lipodystrophy in HIV-infected patients under therapy with the new protease inhibitor atazanavir.
authors.affiliation: Division of Infectious Diseases, Department of Internal Medicine, University Hospital and Medical Center, 89081 Ulm, Germany.
authors.forename: Georg
authors.initials: G
authors.lastname: Haerter
authors.forename: Burkhard J
authors.initials: BJ
authors.lastname: Manfras
authors.forename: Markus
authors.initials: M
authors.lastname: Mueller
authors.forename: Peter
authors.initials: P
authors.lastname: Kern
authors.forename: Andreas
authors.initials: A
authors.lastname: Trein
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D000069446:Atazanavir Sulfate; D005260:Female; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1; D039682:HIV-Associated Lipodystrophy Syndrome / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*
chemical_list: D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate